Galapagos

Uninhabited island full of trees

Biotech

Rebranded biotech lands $125M for rescued Galapagos assets

Coultreon Biopharma’s pipeline of Galapagos castaways is led by COL-5671, an oral SIK3 inhibitor in development for autoimmune diseases.

Darren Incorvaia Apr 28, 2026 7:00am

Gilead and Kites exhibit booth at ASH 2025

Gilead's $2.2B Ouro buy delivers TCE, new purpose for Galapagos

Mar 24, 2026 3:34am

Euros cash money

Galapagos took €228M hit from cell therapy wind-down

Feb 24, 2026 6:30am

Comedy and tragedy masks on red curtain background

Galapagos' last immunology asset posts mixed results

Dec 19, 2025 6:05am

Rotten tomato splat fruit

Fierce Biotech's Rotten Tomatoes of 2025

Dec 16, 2025 4:30am

plan B fail reroute road path trail miss

'Gilead wants us to rebuild': Why Galapagos can't go extinct

Nov 19, 2025 7:50am